Related Experiment Videos
Cromolyn effects on vernal keratoconjunctivitis in children
Archives of Ophthalmology (Chicago, Ill. : 1960)
|December 1, 1977
Summary
Topical cromolyn sodium eye drops effectively treated vernal keratoconjunctivitis symptoms in children. Long-term use of this treatment showed no adverse side effects, offering a safe therapeutic option.
Area of Science:
- Ophthalmology
- Allergology
- Pediatric Medicine
Background:
- Vernal keratoconjunctivitis (VKC) is a severe allergic eye condition affecting children.
- Current treatments for VKC can have limitations or side effects.
- Evaluating safe and effective long-term therapies for VKC is crucial.
Purpose of the Study:
- To assess the efficacy and safety of 2% cromolyn sodium eye drops in treating pediatric VKC.
- To compare the effects of cromolyn sodium against a placebo in a controlled trial.
Main Methods:
- A double-masked, randomized, placebo-controlled trial involving 14 children with VKC.
- One eye of each child was treated with 2% cromolyn sodium eye drops, while the other received a placebo.
- Treatment duration was one year.
Main Results:
- Cromolyn sodium significantly reduced vernal keratitis, corneal ulcers, plaques, and limbal edema/infiltrates.
- The number and size of giant papillae were not affected by cromolyn sodium treatment.
- No adverse side effects were observed with long-term topical cromolyn sodium use.
Conclusions:
- Topical 2% cromolyn sodium eye drops are an effective treatment for several key symptoms of VKC in children.
- Cromolyn sodium demonstrates a favorable safety profile for extended use in pediatric VKC management.
- This study supports cromolyn sodium as a viable therapeutic option for managing pediatric vernal keratoconjunctivitis.